Matthew GlineUS

CEO, Roivant Sciences Ltd. (ROIV) (+1 more)

Net worth (est.)

$784.8M

#266 in the US

¥124B · US-listed shares

Dividends (a year)

CEO pay (a year)

$3.1M

Incl. stock awards

Latest filing

2026-06-30

Form 3/4/5 transaction date

Holdings

Company	Held by	Shares	Price	Value	Dividends
Roivant Sciences Ltd. ROIV · CEO	Direct	16,659,945	$35.80	$596.4M	—
Arbutus Biopharma Corp ABUS	By Roivant Sciences Ltd.	38,847,462	$4.85	$188.4M	—

Estimated from SEC Form 3/4/5 holdings and prices from SEC Fails-to-Deliver and Form 13F data. Options and RSUs excluded. Source: U.S. Securities and Exchange Commission (EDGAR). SEC filings